Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

Introduction: Abnormalities in lipid metabolism may contribute to the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Fenofibrate induces early and reversible reduction in estimated glomerular filtration rate (eGFR), but it may have protective effects on...

Full description

Bibliographic Details
Main Authors: Rebecca Frazier, Rupal Mehta, Xuan Cai, Jungwha Lee, Sara Napoli, Timothy Craven, Jennifer Tuazon, Adam Safdi, Julia Scialla, Katalin Susztak, Tamara Isakova
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024918302043

Internet

http://www.sciencedirect.com/science/article/pii/S2468024918302043

Similar Items